Clinical Trial Update: Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, placebo-controlled trial evaluating an anti-inflammatory treatment for age-associated memory impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Memory Disorders

Snippet

Sponsor: University of California, Los Angeles | Conditions: Memory Disorders | Phase 3 | Status: COMPLETED